FDA advisory committee to discuss future of Covid boosters

FDA advisory committee to discuss future of Covid boosters


A nurses fills up syringes for patients as they receive their coronavirus disease (COVID-19) booster vaccination during a Pfizer-BioNTech vaccination clinic in Southfield, Michigan, September 29, 2021.

Emily Elconin | Reuters

A Food and Drug Administration advisory committee will meet next month to discuss the future of Covid-19 booster shots in the U.S., and whether the vaccines should be updated to target specific variants.

The FDA’s Vaccines and Related Biological Products Advisory Committee will meet April 6 to debate the timing of Covid boosters for the coming months as well as when the shots should be updated to target specific variants. They haven’t scheduled a specific vote nor are they expected to discuss Pfizer or Moderna’s recent applications for fourth Covid vaccine doses.

Public health experts and the vaccine makers have said Covid will eventually become a seasonal virus like the flu, which has higher transmission during the winter months and then recedes when the weather turns warm again. The CEOs of Pfizer and Moderna have both said annual vaccinations against Covid will be necessary similar to the flu, particularly for the elderly and those with underlying conditions.

Ever year, the FDA advisory committee decides which flu vaccine should be administered in the U.S. based on what strain is circulating and other factors. The committee will likely take a similar approach to Covid vaccines moving forward.

“Now is the time to discuss the need for future boosters as we aim to move forward safely, with COVID-19 becoming a virus like others such as influenza that we prepare for, protect against, and treat,” said Dr. Peter Marks, the head of the FDA’s vaccine safety group.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:



Source

The vaccine and public health debate at the center of CDC upheaval, explained
Health

The vaccine and public health debate at the center of CDC upheaval, explained

The exterior of the Center for Disease Control and Prevention (CDC) main campus in Atlanta, Georgia, U.S., Aug. 27, 2025. Alyssa Pointer | Reuters The Centers for Disease Control and Prevention is facing a leadership upheaval — and at the center of the shakeup is concern about the agency’s approach to vaccines and U.S. public […]

Read More
CDC Director Susan Monarez ousted, four other leaders quit health agency
Health

CDC Director Susan Monarez ousted, four other leaders quit health agency

Susan Monarez, President Donald Trump’s nominee to be the Director of the Centers for Disease Control and Prevention (CDC), testifies during her confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions in the Dirksen Senate Office Building on June 25, 2025 in Washington, DC. Kayla Bartkowski | Getty Images Centers for Disease […]

Read More
FDA approves new Covid shots with limits on who can get them, as RFK Jr. changes vaccine precedents
Health

FDA approves new Covid shots with limits on who can get them, as RFK Jr. changes vaccine precedents

Pfizer’s Covid vaccine Comirnaty, seen at a CVS Pharmacy in Eagle Rock, California, Sept. 14, 2023. Irfan Khan | Los Angeles Times | Getty Images The Food and Drug Administration on Wednesday approved the latest round of Covid vaccines in the U.S., but set new limits on who can get them. The agency ended its […]

Read More